Ischemic renal diseases: New insights into old entities

Kidney International

Volumn 54, Issue 1, 1998, Pages 2-13

  Meyrier, Alain ^a   Hill, Gary S ^b   Simon, Pierre ^b  

^a HÔPITAL BROUSSAIS   (France)

^b NONE

Author keywords

Angiotensin II; Atherosclerotic renal disease; Black race; Cholesterol crystal embolism; Chronic renal insufficiency; Focal segmental glomerulosclerosis; Hypertension; Nephrosclerosis; Renal fibrosis; Renal ischemia; Renin angiotensin system; Renovasculopathies

Indexed keywords

ANGIOTENSIN;

GLOMERULOSCLEROSIS; HUMAN; HYPERTENSION; KIDNEY BLOOD VESSEL; KIDNEY FAILURE; KIDNEY ISCHEMIA; NEPHROSCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW;

EID: 0031863011     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00968.x     Document Type: Article

References (134)

1. FAHR T: Über Nephrosklerose. Virchows Arch (Pathol Anat) 26:119-178, 1919
2. VOLHARD F: D. Die Sklerosen, in Die doppelseitigen hämatogenen Nierenerkrankungen (Brightsche Krankheit), Berlin, J. Springer Verlag, 1918, p 491
3. RITZ E, FLISER D, SIEBELS M: Pathophysiology of hypertensive renal damage. Am J Hypertens 6:241S-244S, 1993
4. KASHGARIAN M: Hypertensive disease and kidney structure, in Hypertension: Pathophysiology, Diagnosis and Management, edited by LARAGH JH, BRENNER BM, New York, Raven Press, 1990, p 389
5. ZUCCHELLI P, ZUCCALA A: Mechanism of progression, the role of vascular injury/sclerosis, in Prevention of Progressive Chronic Renal Failure, edited by EI. NAHAS AM, MALLICK NP, ANDERSON S, Oxford, Oxford University Press, 1993, p 98
6. LUKE RG, CURTIS JJ: Nephrosclerosis, in Diseases of the Kidney, edited by SCHRIER RW, GOTTSCHALK CW, Boston, Little, Brown & Company, 1993, p 1433
7. HELMCHEN U, WENZEL UO: Benign and malignant nephrosclerosis and renovascular disease, in Renal Pathology, edited by TISHER CC, BRENNER BM, Philadelphia, J.B. Lippincott Company, 1994, p 1201
8. TRACY RE, VELEZ-DURAN M, HEIGLE T, OALMANN MC: Two variants of nephrosclerosis separately related to age and blood pressure. Am J Pathol 131:270-282, 1988
9. TRACY RE, STRONG JP, NEWMAN WPI, MALCOM GT, OALMANN MC, GUZMAN MA: Renovasculopathies of nephrosclerosis in relation to atherosclerosis at ages 25 to 54 years. Kidney Int 49:564-570, 1996
10. HEPTINSTALL RH: Hypertension: II. Essential hypertension, in Pathology of the Kidney, edited by HEPTINSTALL RH, Boston/Toronto, Little, Brown & Company, 1983, p 181
11. MEYRIER A, SIMON P: Nephroangiosclerosis and hypertension: Things are not as simple as you might think. Nephrol Dial Transplant 11:2116-2120, 1996
12. FREEDMAN BI, ISKANDAR SS, APPEL RG: The link between hypertension and nephrosclerosis. Am J Kidney Dis 25:207-221, 1995
13. FOGO A, BREYER JA, SMITH MC, CLEVELAND WH, AGODOA L, KIRK KA, GLASSOCK R. THE AASK PILOT STUDY INVESTIGATORS: Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report of the African American Study of Kidney Disease (AASK) trial, Kidney Int 51:244-252, 1997
14. LUKE RG: Essential hypertension: A renal disease? Hypertension 21:380-390, 1993
15. LOPES AAS, PORT FK, JAMES SA, AGODOA L: The excess risk of treated end-stage renal disease in Blacks in the United States. J Am Soc Nephrol 3:1961-1971, 1993
16. KAPLAN NM: Ethnic aspects of hypertension. Lancet 344:450-452, 1994
17. CORESH J, JAAR B: Further trends in the etiology of end-stage renal disease in African-Americans. Curr Opin Nephrol Hypertens 6:243-249, 1997
18. WILSON TW, GRIM CE: Biohistory of slavery and blood pressure differences in blacks today. A hypothesis. Hypertension 17:1-122-1-128, 1991
19. DUSTAN HP: Growth factors and racial differences in severity of hypertension and renal diseases. Lancet 339:1339-1340, 1992
20. QUALHEIM RE, ROSTAND SG, KIRK KA, RUTSKY EA. LUKE RG: Changing patterns of end-stage renal disease due to hypertension. Am J Kidney Dis 18:336-343, 1991
21. WEISSTUCH JM, DWORKIN LD: Does esssential hypertension cause end-stage renal disease? Kidney Int 41:33-37, 1992
22. TRACY RE, GUZMAN MA, OALMANN MC, NEWMAN WP, STRONG JP: Nephrosclerosis in three cohorts of Black and White men born 1925 to 1944, 1934 to 1953 and 1943 to 1962. Am J Hypertens 6:185-192, 1993
23. TRACY RE, MALCOM GT, OALMANN MC, QURESHI U, ISHII T, VELEZ-DURAN M: Renal microvascular features of hypertension in Japan, Guatemala, and USA. Arch Pathol Lab Med 116:50-55, 1992
24. TRACY RE: Renovasculopathies of hypertension and the rise of blood pressure with age in Blacks and Whites. Semin Nephrol 16:126-133, 1996
25. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRITZL P, FLOEGE J, SCHWARTZ SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
26. FELD LG, VAN LIEW JB, BRENTJENS JR, BOYLAN JW, BEMBEN S, CHANG H, MANZ N: Renal lesions and proteinuria in the spontaneously hypertensive rat made normotensive by treatment. Kidney Int 20:606-614, 1981
27. SMEDA JS, LEE RM, FORREST JB: Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension. Circ Res 63:534-542, 1988
28. SMEDA JS, LEE RM, FORREST JB: Structural and reactivity alterations of the renal vasculature of spontaneously hypertensive rats prior to and during established hypertension. Circ Res 63:518-533, 1988
29. KREGE JH, JOHN SWM, LANGENBACH LL, HODGIN JB, HAGAMAN JR, BACHMAN ES, JENNETTE JC, O'BRIEN DA, SMITHIES O: Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146-148, 1995
30. KIM HS, KREGE JH, KLUCKMAN KD, HAGAMAN JR, HODGIN JB, BEST CF, JENNETTE JC, COFFMAN TM, MAEDA N, SMITHIES O: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 92:2735-2739, 1995
31. NIIMURA F, LABOSKY PA, KAKUCHI J, OKUBO S, YOSHIDA H, OIKAWA T, ICHIKI T, NAFTILAN AJ, FOGO A, INAGAMI T, HOGAN BL, ICHIKAWA I: Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96:2947-2954, 1995
32. HOCHER B, THÖNE-REINEKE C, ROHMEISS P, SCHMAGER F, SLOWINSKI T, BURST V, SIEGMUND F, QUERTERMOUS T, BAUER C, NEUMAYER HH, SCHLEUNING WD, THEURING F: Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99:1380-1389, 1997
33. VÉNIANT M, MÉNARD J, BRUNEVAL P, MORLEY S, GONZALES MF, MULLINS J: Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest 98:1966-1970, 1996
34. POUTASSE EF, HUMPHRIES AW, MCCORMACK LJ, CORCORAN AC: Bilateral stenosis of renal arteries and hypertension. Treatment by arterial homografts. JAMA 161:419-423, 1956
35. BREYER JA, JACOBSON HR: Ischemic nephropathy. Curr Opin Nephrol Hypertens 2:216-224, 1993
36. JACOBSON HR: Ischemic renal disease: An overlooked clinical entity? Kidney Int 34:729-743, 1988
37. MEYRIER A, BUCHET P, SIMON P, FERNET M, RAINFRAY M, CALLARD P: Atheromatous renal disease. Am J Med 85:139-146, 1988
38. OLIN JW, MELIA M, YOUNG JR, GRAOR RA, RISIUS B: Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 88(1N):46N-51N, 1990
39. NOVICK AC: Management of renovascular disease. A surgical perspective. Circulation 83:167-171, 1991
40. TOLLEFSON DFJ, ERNST CB: Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vase Surg 14:327-331, 1991
41. MAILLOUX LU, NAPOLITANO B, BELLUCCI AG, VERNACE M, WILKES BM, MOSSEY RT: Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: A 20-year clinical experience. Am J Kidney Dis 24:622-629, 1994
42. APPEL RG, BLEYER AJ, REAVIS S, HANSEN KJ: Renovascular disease in older patients beginning renal replacement therapy. Kidney Int 48:171-176, 1995
43. GRECO BA, BREYER JA: Atherosclerotic ischemic renal disease. Am J Kidney Dis 29:167-187, 1997
44. PLOUIN PF, JEUNEMAITRE X, CHATELLIER G, JULIEN J, RAYNAUD A: Intérêt et limites de l'exploration des artères rénales chez les hypertendus âgés. Néphrologie 11:297-299, 1990
45. VETROVEC GW, LANDWEHR DM, EDWARDS VL: Incidence of renal artery stenosis in hypertensive patients undergoing coronary angiography. J Interven Cardiol 2:69-76, 1989
46. HARDING MB, SMITH LR, HIMMELSTEIN SI, HARRISON K, PHILLIPS HR, SCHWAB SJ, HERMILLER JB, DAVIDSON CJ, BASHORE TM: Renal artery stenosis: Prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 2:1608-1616, 1992
47. RAMIREZ G, BUGNI W, FARBER SM, CURRY AJ: Incidence of renal artery stenosis in a population having cardiac catheterization. South Med J 80:734-737, 1987
48. HANSEN KJ: Prevalence of ischemic nephropathy in the atherosclerotic population. Am J Kidney Dis 24:615-621, 1994
49. OLIN JW, PIEDMONTE MR, YOUNG JR, DEANNA S, GRUBB M, CHILDS MB: The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med 122:833-838, 1995
50. KEITH TA: Renovascular hypertension in black patients. Hypertension 4:438-443, 1982
51. DIEZ-ROUX AV, NIETO FJ, TYROLER HA, CRUM LD, SZKLO M: Social inequalities and atherosclerosis. The atherosclerosis risk in communities study. Am J Epidemiol 141:960-972, 1995
52. ARNETT DK, TYROLER HA, BURKE G, HUTCHINSON R, HOWARD G, HEISS G: Hypertension and subclinical carotid artery atherosclerosis in blacks and whites. The atherosclerosis risk in communities study ARIC investigators. Arch Intern Med 156:1983-1989, 1996
53. DAVIS BA, CROOK JE, VESTAL RE, OATES JA: Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. N Engl J Med 301:1273-1276, 1979
54. SAKLAYEN MG: Atheroembolic renal disease: Preferential occurrence in whites only. Am J Nephrol 9:87-88, 1989
55. MORGAN T, WILSON M, JOHNSTON W, CLUNIE GJ, GORDON R: Restoration of renal function by arterial surgery. Lancet 2:653-656, 1974
56. NOVICK AC, TEXTOR SC, BODIE B, KHAULI RB: Revascularization to preserve renal function in patients with atherosclerotic renovascular disease. Urol Clin North Am 11:477-490, 1984
57. MORAN K, MULHALL J, KELLY D, SHEEHAN S, DOWSETT J, DERVAN P, FITZPATRICK JM: Morphological changes and alterations in regional intrarenal blood flow induced by graded renal ischemia. J Urol 148:463-466, 1992
58. SIGMAN DH, BEIERWALTES WH: Renal nitric oxide and angiotensin II interaction in renovascular hypertension. Hypertension 22:237-262, 1993
59. ANDERSON WP, WOODS RL: Intrarenal effects of angiotensin II in renal artery stenosis. Kidney Int 31(Suppl 20):S157-S167, 1987
60. HRICIK DE, BROWNING PJ, KOPELMAN R, GOORNO WE, MADIAS NE, DZAU VJ: Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal-artery stenosis in a solitary kidney. N Engl J Med 308:373-376, 1983
61. YING CY, TIFFT CP, GAVRAS H, CHOBANIAN AV: Renal revascularization in the azotemic hypertensive patient resistant to therapy. N Engl J Med 311:1070-1075, 1984
62. TEXTOR SC, NOVICK AC, TARAZI RC, KLIMAS V, VIDT DG, POHL M: Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease. Ann Intern Med 102:308-314, 1985
63. TEXTOR SC: Pathophysiology of renal failure in renovascular disease. Am J Kidney Dis 24:642-651, 1994
64. SHANLEY PF: The pathology of chronic renal ischemia. Semin Nephrol 16:21-32, 1996
65. TAYLOR A JR, ESHIMA D: Renal artery stenosis and ischemia. Effect on renal blood flow and extraction fraction. Hypertension 23:96-103, 1994
66. KELLERMAN PS: Cellular and metabolic consequences of chronic ischemia on kidney function. Semin Nephrol 16:33-42, 1996
67. GOBÉ GC, AXELSEN RA, SEARLE JW: Cellular events in experimental unilateral ischemic renal atrophy and in regeneration after contralateral nephrectomy. Lab Invest 63:770-779, 1990
68. TRUONG LD, FARHOOD A, TASBY J, GILLUM D: Experimental chronic renal ischemia: Morphologic and immunologic studies. Kidney Int 41:1676-1689, 1992
69. RIMMER JM, GENNARI J: Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 118:712-719, 1993
70. THADHANI RI, CAMARGO CA JR, XAVIER RJ, FANG LS, BAZARI H: Atheroembolic renal failure after invasive procedures: Natural history based on 52 histologically proven cases. Medicine 74:350-358, 1995
71. FINE MJ, KAPOOR W, FALANGA V: Cholesterol crystal embolization: A review of 221 cases in the English literature. Angiology 38:769-784, 1987
72. OM A, ELLAHHAM S, DI SCIASCIO G: Cholesterol embolism: An underdiagnosed clinical entity. Am Heart J 124:1321-1326, 1992
73. MEYRIER A, SIMON P, MONTSENY JJ, ELADARI D, CHARASSE C: Vascular nephropathies and nephrosclerosis: Epidemiology and pathophysiology, in Advances in Nephrology, edited by GRUNFELD JP, BACH JF, KRES H, MAXWELL MH, Chicago, Mosby Yearbook Publishers, 1996, p 207
74. GREENBERG A, BASTACKY SI, IQBAL A, BOROCHOVITZ D, JOHNSON JP: Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: Clinicopathological correlations. Am J Kidney Dis 29:334-344, 1997
75. BELEFANT X, BARIÉTY J, MEYRIER A, JACQUOT C: An intensive care, adapted Rx schedule reduces mortality in multivisceral cholesterol emboli (MCE) with acute renal failure (ARF). Experience in 67 cases, (abstract) J Am Soc Nephrol 8:122A, 1997
76. EDDY AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495-2508, 1996
77. BOHLE A, MÜLLER GA, WEHRMANN M, MACKENSEN-HAEN S, XIAO J-C: Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic intersitial nephritides. Kidney Int 49(Suppl 54):S2-S9, 1997
78. NATH KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17, 1992
79. HILL GS, CLARK RL: A comparative angiographic, microangio-graphic, and histologic study of experimental pyelonephritis. Invest Radiol 7:33-47, 1972
80. KLAHR S: New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis 18:689-699, 1991
81. KLAHR S, ISHIDOYA S, MORRISSEY J: Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis 26:141-146, 1995
82. KANETO H, MORRISSEY J, KLAHR S: Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44:313-321, 1993
83. D'AGATI VD: Morphologic features of cyclosporin nephrotoxicity, in Cyclosporin in the Treatment of Renal Disease, edited by TEJANI A, Basel, Karger, 1995, p 84
84. MEYRIER A, NOEL LH, AURICHE P, CALLARD P: Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Kidney Int 45:1446-1456, 1994
85. PICHLER RH, FRANCESCHINI N, YOUNG BA, HUGO C, ANDOH TF, BURDMANN EA, SHANKLAND SJ, ALPERS CE, BENNETT WM, COUSER WG, JOHNSON RJ: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196, 1995
86. SHIHAB FS, ANDOH TF, TANNER AM, BENNETT WM: Sodium depletion enhances fibrosis and the expression of TGF-beta 1 and matrix proteins in experimental chronic cyclosporine nephropathy. Am J Kidney Dis 30:71-81, 1997
87. SHIHAB FS, BENNETT WM, TANNER AM, ANDOH TF: Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy. Kidney Int 52:660-673, 1997
88. FOGO A, HELLINGIS SE, INAGAM T, KON V: Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity Kidney Int 42:770-774, 1992
89. KOHNO M, MORIO T, IKEDA M, YOKOKAWA K, FUKUI T, YASUNARI K, KURIHARA N, TAKEDA T: Angiotensin II stimulates endothelin-I secretion in cultured rat mesangial cells. Kidney Int 42:860-866, 1992
90. CHAN PC, CLAVELL A, KEISER J, BURNETT JCJ: Effects of reninangiotensin system in mediating endothelin-induced renal vasoconstriction: Therapeutic implications. J Hypertens 12:S43-S49, 1994
91. KIM S, OHTA K, HAMAGUCHI A, OMURA T, YUKIMURA T, MIURA K, INADA Y, WADA T, ISHIMURA Y, CHATANI F, IWAO H: Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kidney Int 46:1346-1358, 1994
92. HAMAGUCHI A, KIM S, OHTA K, YAGI K, YUKIMURA T, MIURA K, FUKUDA T, IWAO H: Transforming growth factor-β 1 expression and phenotypic modulation in the kidney of hypertensive rats. Hypertension 26:199-207, 1995
93. GIBBONS GH, PRATT RE, DZAU VJ: Vascular smooth muscle cell hypertrophy vs. hyperplasia: Autocrine transforming growth factor β-1 expression determines growth response to angiotensin II. J Clin Invest 90:456-461, 1992
94. KANETO H, MORRISSEY J, MCCRACKEN R, REYES A, KLAHR S: Enalapril reduces collagen type IV and expansion of interstitium in the obstructed rat kidney. Kidney Int 45:1637-1647, 1994
95. GRONE HJ, HELMCHEN U: Impairment and recovery of the clipped kidney in two kidney, one clip hypertensive rats during and after antihypertensive therapy. Lab Invest 54:645-655, 1986
96. MASCHIO G, ALBERTI D, JANIN G, LOCATELLI F, MANN JFE, MOTOLESE M, PONTICELLI C, RITZ E, ZUCCHELLI P, ANGIOTENSIN-CONVERTING-ENZYME INHIBITION IN PROGRESSIVE RENAL INSUFFICIENCY STUDY GROUP: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996
97. SOMMERS S, MELAMED J: Renal pathology of essential hypertension. Am J Hypertens 3:583-587, 1990
98. OKADA H, SUZUKI H, KANNO Y, IKENAGA H, SARUTA T: Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats. J Cardiovasc Pharmacol 26:564-569, 1995
99. NOCHY D, BARRES D, CAMILLERI JP, BARIÉTY J, CORVOL P, MÉNARD J: Abnormalities of renin-containing cells in human glomerular and vascular renal diseases. Kidney Int 23:375-379, 1983
100. EL NAHAS AM: Renal scarring: The role of angiotensin II. Nephrol Dial Transplant 10:28-32, 1995
101. MATSUSAKA T, HYMES J, ICHIKAWA I: Angiotensin in progressive renal diseases: Theory and practice. Am J Kidney Dis 7:2025-2043, 1996
102. PETTINGER WA, LEE HC, REISCH J, MITCHELI HC: Long term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis. Hypertension 13:766-772, 1989
103. TOTO RD, MITCHELL HC, SMITH RD, LEE HC, MCINTIRE D, PETTINGER WA: "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int 48:851-859, 1995
104. ANDERSON S, RENNKE HG, BRENNER BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
105. PEDAGOGOS E, HEWTTSON T, FRASER I, NICHOLLS K, BECKER G: Myofibroblasts and arteriolar fibrosis in human diabetic nephropathy. Am J Kidney Dis 29:912-918, 1997
106. GOUMENOS D, BROWN CB, SHORTLAND J, EL NAHAS AM: Myofibroblasts, prediction of progression of IgA nephropathy. Nephrol Dial Transplant 9:1418-1425, 1994
107. HEWITSON TD, BECKER GJ: Interstitial myofibroblasts in IgA glomerulonephritis. Am J Nephrol 15:111-117, 1995
108. PICHLER RH, HUGO C, SHANKLAND SJ, REED MJ, BASSUK JA, ANDOH TF, LOMBARDI DM, SCHWARTZ SM, BENNETT WM, ALPERS CE, SAGE EH, JOHNSON RJ, COUSER WG: SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int 50:1978-1989, 1996
109. WU LL, COX A, ROE CJ, DZIADEK M, COOPER ME, GILBERT RE: Secreted Protein Acidic and Rich in Cysteine expression after subtotal nephrectomy and blockade of the renin-angiotensin system. J Am Soc Nephrol 8:1373-1382, 1997
110. D'AGATI V: The many masks of focal segmental glomerulosclerosis. Kidney Int 46:1223-1241, 1994
111. RENNKE HG, KLEIN PS: Pathogenesis and significance of nonprimary focal and segmental glomeruloselerosis. Am J Kidney Dis 13:443-456, 1989
112. SCHWARTZ MM, LEWIS EJ: Focal segmental glomerular sclerosis: The cellular lesion. Kidney Int 28:968-974, 1985
113. KRIZ W, ELGER M, NAGATA M, KRETZLER M, UIKER S, KOEPPENHAGEMANN I, TENSCHERT S, LEMLEY KV: The role of podocytes in the development of glomerular sclerosis. Kidney Int 45(Suppl 45): S64-S72, 1994
114. HOSTETTER TH, OLSON JL, RENNKE HG: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85-F93, 1981
115. KRIZ W: Progressive renal failure-Inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transpl 11:1738-1742, 1996
116. ANDERSON S, DIAMOND JR, KARNOVSKY MJ, BRENNER BM: Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 82:1757-1768, 1988
117. MCMANUS JFA, LUPTON CHJ: Ischemic obsolescence of renal glomeruli. The natural history of the lesions and their relation to hypertension. Lab Invest 9:413-434, 1960
118. OGUMA S: A histometrical study on the development of three glomerulopathies. Kidney Int 34:102-108, 1988
119. GEPHARDT GN, TUBBS R, NOVICK AC, MCMAHON JT, POHL MA: Renal artery stenosis, nephrotic-range proteinuria, and focal and segmental glomerulosclerosis. Cleveland Clin Q 51:371-376, 1984
120. THADANI R, PASCUAL M, NICKELEIT V, TOLKOFF-RUBIN N, COLVIN R: Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease. Lancet 347:231-233, 1996
121. MILLER PL, RENNKE HG, MEYER TW: Glomerular hypertrophy accelerates hypertensive glomerular injury in rats. Am J Physiol 261:F459-F465, 1991
122. KASISKE BL: Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 31:1153-1159, 1987
123. DIAMOND JR, KARNOVSKY MJ: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 33:917-924, 1988
124. KINCAID-SMITH P: Vascular lesions associated with idiopathic glomerular lesions, in The Kidney, A Clinico-Pathological Study, edited by KINCAID-SMITH P, Oxford, Blackwell Scientific Publications, 1975, p 193
125. RAIJ L, AZAR S, KEANE W: Role of hypertension in progressive glomerular injury. Hypertension 7:398-400, 1985
126. GALLO GR, FEINTER JM, STEELE JM, SCHACHT RG, GLUCK MC, BALDWIN DS: Role of intrarenal vascular sclerosis in progression of poststreptococcal glomerulonephritis. Clin Nephrol 13:49-57, 1980
127. STEIN-OAKLEY AN, MAGUIRE JA, DOWLING J, PERRY G, THOMSON NM: Altered expression of fibrogenic growth factors in IgA nephropathy and focal and segmental glomerulosclerosis. Kidney Int 51:195-204, 1997
128. RADFORD MGJ, DONADIO JVJ, BERGSTRALH EJ, GRANDE JP: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8:199-207, 1997
129. CAMERON JS: Membranous nephropathy and its treatment. Nephrol Dial Transpl 7(Suppl 1):72-79, 1992
130. TEJANI A: Morphological transition in minimal change nephrotic syndrome. Nephron 39:157-159, 1985
131. WAKAI S, MAGIL AB: Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney Int 42:428-434, 1992
132. LEE HS, KOH HI: Nature of progressive glomerulosclerosis in human membranous nephropathy. Clin Nephrol 39:7-16, 1993
133. PAGTALUNAN ME, MILLER PL, JUMPING-EAGLE S, NELSON RG, MYERS BD, RENNKE HG, COPLON NS, SUN L, MEYER TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99:342-348, 1997
134. KATAFUCHI R, OH Y, HORI K, KOMOTA T, YANASE T, IKEDA K, OMURA T, FUJIMI S: An important role of glomerular segmental lesions on progression of IgA nephropathy. Clin Nephrol 41:191-198, 1994